32 related articles for article (PubMed ID: 7226702)
1. beta-blockers. Drug interactions of clinical significance.
Blaufarb I; Pfeifer TM; Frishman WH
Drug Saf; 1995 Dec; 13(6):359-70. PubMed ID: 8652080
[TBL] [Abstract][Full Text] [Related]
2. Social drinking and drugs.
Orme ML
Br Med J (Clin Res Ed); 1981 Dec; 283(6305):1489-90. PubMed ID: 6799035
[No Abstract] [Full Text] [Related]
3. Ethanol-induced inhibition of hepatic uptake of propranolol in perfused rat liver and in man.
Dorian P; Sellers EM; Kaplan HL; Carruthers G; Hamilton C; Khouw V
Eur J Clin Pharmacol; 1984; 27(2):209-15. PubMed ID: 6499899
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
5. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
Singh BN; Deedwania P; Nademanee K; Ward A; Sorkin EM
Drugs; 1987 Sep; 34(3):311-49. PubMed ID: 3315621
[TBL] [Abstract][Full Text] [Related]
6. The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats.
Berkan T; Ustünes L; Kerry Z; Karol M; Tosun M; Yalçinkaya C; Ozer A
Eur J Drug Metab Pharmacokinet; 1989; 14(3):221-8. PubMed ID: 2612519
[TBL] [Abstract][Full Text] [Related]
7. Propranolol in the treatment of angina: a review.
Prichard BN
Postgrad Med J; 1976; 52 Suppl 4():35-41. PubMed ID: 787954
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
9. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
[TBL] [Abstract][Full Text] [Related]
10. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
Garvey HL; Ram N
J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
Aro A; Anttila M; Korhonen T; Sundquist H
Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
[TBL] [Abstract][Full Text] [Related]
12. A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.
Funck-Brentano C; Silberstein DJ; Roden DM; Wood AJ; Woosley RL
Br J Clin Pharmacol; 1990 Aug; 30(2):195-202. PubMed ID: 2169833
[TBL] [Abstract][Full Text] [Related]
13. Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Anttila M; Sundqvist H
Br J Clin Pharmacol; 1980 Apr; 9(4):399-405. PubMed ID: 7378257
[TBL] [Abstract][Full Text] [Related]
14. Propranolol and sotalol metabolism after a drinking party.
Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
